Parabilis Medicines, Inc. (PBLS)
40.11
+0.64
(+1.62%)
USD |
NASDAQ |
Sep 02, 16:00
40.98
+0.87
(+2.17%)
Pre-Market: 09:22
Parabilis Medicines Research and Development Expense (TTM) : 140.96M for June 30, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 140.96M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Moderna, Inc. | 2.635B |
| Kailera Therapeutics, Inc. | -- |
| Arrowhead Pharmaceuticals, Inc. | 699.56M |
| Oncolytics Biotech, Inc. | 13.11M |
| Sangamo Therapeutics, Inc. | 113.79M |